SPRYCEL 50 mg/1
dasatinib · TABLET · E.R. Squibb & Sons, L.L.C.
Sprycel (dasatinib) is an oral tablet taken by mouth that is used to treat certain types of blood cancers, including chronic myeloid leukemia and acute lymphoblastic leukemia. It works by blocking proteins that help cancer cells grow and divide.
Key Facts
- Brand Name
- SPRYCEL
- Generic Name
- dasatinib
- NDC Code (Product)
0003-0528- Manufacturer
- E.R. Squibb & Sons, L.L.C.
- Strength
- 50 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- NDA021986
- Marketing Start
- 06/27/2006
Recall History
Kroger Specialty Pharmacy, Inc.
Lack of Processing Controls.
Kroger Specialty Pharmacy, Inc.
Lack of Processing Controls.
Side Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Frequently Asked Questions
What is SPRYCEL used for?
Sprycel (dasatinib) is an oral tablet taken by mouth that is used to treat certain types of blood cancers, including chronic myeloid leukemia and acute lymphoblastic leukemia. It works by blocking proteins that help cancer cells grow and divide.
Is SPRYCEL a controlled substance?
SPRYCEL is not classified as a controlled substance by the DEA.
What is the generic name for SPRYCEL?
The generic name for SPRYCEL is dasatinib. There are 10 other brand versions of dasatinib.
What is the NDC code for SPRYCEL 50 mg/1?
The NDC (National Drug Code) for SPRYCEL 50 mg/1 is 0003-0528, listed by E.R. Squibb & Sons, L.L.C..